Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.02)
# 1,096
Out of 4,829 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $164.55 | +6.35% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $78.72 | -23.78% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $22.00 | +218.18% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $110.91 | +3.69% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $74.07 | +8.01% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $1.77 | +4,137.29% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $164.55
Upside: +6.35%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $78.72
Upside: -23.78%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $22.00
Upside: +218.18%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $110.91
Upside: +3.69%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $74.07
Upside: +8.01%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $1.77
Upside: +4,137.29%